Sanofi Inks Antibody Deals Targeting Infections and Alzheimer’s
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 12 (Table of Contents)
Published: 18 Dec-2009
DOI: 10.3833/pdr.v2009.i12.1288 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Sanofi-aventis has joined the league of big pharma targeting infectious diseases by entering into collaboration with Alopexx Pharmaceuticals to produce a novel antibody...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS